Essex Bio-Technology Limited (HKG:1061)
3.000
-0.040 (-1.32%)
Jun 1, 2026, 3:59 PM HKT
Essex Bio-Technology Revenue
In the year 2025, Essex Bio-Technology had annual revenue of 1.81B HKD with 8.62% growth. Essex Bio-Technology had revenue of 937.27M in the half year ending December 31, 2025, with 11.90% growth.
Revenue
1.81B
Revenue Growth
+8.62%
P/S Ratio
0.94
Revenue / Employee
1.41M
Employees
1,289
Market Cap
1.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.81B | 143.99M | 8.62% |
| Dec 31, 2024 | 1.67B | -67.16M | -3.87% |
| Dec 31, 2023 | 1.74B | 419.26M | 31.82% |
| Dec 31, 2022 | 1.32B | -319.95M | -19.54% |
| Dec 31, 2021 | 1.64B | 659.55M | 67.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chia Tai Enterprises International | 3.68B |
| Edding Genor Group Holdings | 2.77B |
| Jacobson Pharma Corporation | 1.53B |
| Dawnrays Pharmaceutical (Holdings) | 1.37B |
| Golden Throat Holdings Group Company | 1.05B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.00B |
| JBM (Healthcare) | 812.98M |
| Hua Medicine (Shanghai) | 548.54M |
Essex Bio-Technology News
- 2 months ago - Essex Bio-Technology Annual report: H2 2025 - Filings
- 2 months ago - Essex Bio-Technology Earnings release: H2 2025 - Filings
- 9 months ago - Essex Bio-Technology Quarterly report: H1 2025 - Filings
- 9 months ago - Essex Bio-Technology Earnings release: H1 2025 - Filings